bioMerieux S.A. Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	53
ISBN Number	not applicable
Product Code	GMD04827

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a bioMerieux S.A.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - In Vitro Diagnostics
- 2.5 SWOT Snapshot
3 bioMerieux S.A. Pipeline Products
- 3.1 bioMerieux S.A. Product Pipeline Analysis
  - 3.1.1 bioMerieux S.A. Pipeline Products By Equipment Type
  - 3.1.2 bioMerieux S.A. Pipeline Products By Development Stage
  - 3.1.3 bioMerieux S.A. Pipeline Products By Therapy Area
  - 3.1.4 bioMerieux S.A. Pipeline Products By News Summary
- 3.2 VIDAS
  - 3.2.1 Product Description
  - 3.2.2 Product Status
  - 3.2.3 Product Milestone
- 3.3 mini VIDAS
  - 3.3.1 Product Description
  - 3.3.2 Product Status
- 3.4 DAVINCI
  - 3.4.1 Product Description
  - 3.4.2 Product Status
- 3.5 API 20NE
  - 3.5.1 Product Description
  - 3.5.2 Product Status
- 3.6 API NH
  - 3.6.1 Product Description
  - 3.6.2 Product Status
- 3.7 API Staph
  - 3.7.1 Product Description
  - 3.7.2 Product Status
- 3.8 RAPIDEC Staph
  - 3.8.1 Product Description
  - 3.8.2 Product Status
- 3.9 Slidex Staph-Kit
  - 3.9.1 Product Description
  - 3.9.2 Product Status
- 3.10 API 20 Strep
  - 3.10.1 Product Description
  - 3.10.2 Product Status
- 3.11 API Coryne
  - 3.11.1 Product Description
  - 3.11.2 Product Status
- 3.12 Slidex Strepto-Kit
  - 3.12.1 Product Description
  - 3.12.2 Product Status
- 3.13 API 20A
  - 3.13.1 Product Description
  - 3.13.2 Product Status
- 3.14 NucliSENS CMV pp67
  - 3.14.1 Product Description
  - 3.14.2 Product Status
- 3.15 NucliSENS HIV-1 QT
  - 3.15.1 Product Description
  - 3.15.2 Product Status
- 3.16 NucliSENS Isolation Kit
  - 3.16.1 Product Description
  - 3.16.2 Product Status
- 3.17 API 20E
  - 3.17.1 Product Description
  - 3.17.2 Product Status
- 3.18 API Rapid 20E
  - 3.18.1 Product Description
  - 3.18.2 Product Status
- 3.19 Rapid ID 32A
  - 3.19.1 Product Description
  - 3.19.2 Product Status
- 3.20 API 20C AUX
  - 3.20.1 Product Description
  - 3.20.2 Product Status
- 3.21 API 50 CH
  - 3.21.1 Product Description
  - 3.21.2 Product Status
- 3.22 PSA Measurement
  - 3.22.1 Product Description
  - 3.22.2 Product Status
- 3.23 Quicker Tuberculosis Diagnosis
  - 3.23.1 Product Description
  - 3.23.2 Product Status
- 3.24 Test for breast cancer screening using biomarkers
  - 3.24.1 Product Description
  - 3.24.2 Product Status
- 3.25 Test for colon cancer using biomarkers
  - 3.25.1 Product Description
  - 3.25.2 Product Status
- 3.26 Test for prostate cancer using biomarkers
  - 3.26.1 Product Description
  - 3.26.2 Product Status
- 3.27 PREVI Color Gram
  - 3.27.1 Product Description
  - 3.27.2 Product Status
  - 3.27.3 Product Milestone
- 3.28 PREVI Color TB
  - 3.28.1 Product Description
  - 3.28.2 Product Status
  - 3.28.3 Product Milestone
4 Business Description
- 4.1 Business Overview
- 4.2 Clinical Applications
  - 4.2.1 Overview
  - 4.2.2 Financials
  - 4.2.3 Key Strategies
- 4.3 Industrial Applications
  - 4.3.1 Overview
  - 4.3.2 Financials
  - 4.3.3 Market View
  - 4.3.4 Key Strategies
- 4.4 Major Products and Services
  - 4.4.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
11 Financial Deals Landscape
- 11.1 Acquisition
  - 11.1.1 St. Jude Medical Acquires Advanced Neuromodulation Systems
  - 11.1.2 Advanced Neuromodulation Systems Sells Its Stake In Cyberonics
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
List of Tables
- Table 1: bioMerieux S.A.,Key Facts
- Table 2: bioMerieux S.A. Pipeline Products by Equipment Type
- Table 3: bioMerieux S.A. Pipeline Products By Development Stage
- Table 4: bioMerieux S.A. Pipeline Products By Therapy Area
- Table 5: bioMerieux S.A. Pipeline Products By News Summaries
- Table 6: bioMerieux S.A., Key Employees,
- Table 7: bioMerieux S.A., Subsidiaries
List of Figures
- Figure 1: bioMerieux S.A. Pipeline Products By Equipment Type
- Figure 2: bioMerieux S.A. Pipeline Products By Equipment Type
- Figure 3: Global Markets Direct Methodology